Professor Lawrence Wein, Jeffrey S. Skoll Professor of Management Science, explains why childhood obesity screening may not be that useful.
A professor of organizational behavior argues that "human sustainability" may pay off too.
The success of an innovative new therapy suggests new avenues for incorporating emotional health resources into educational systems worldwide.
A physician-turned-administrator at Kaiser Permanente discusses cost-effective innovations that improve care.
How a New York-based company is trying to make surgery in the developing world a lot easier.
Professor Lawrence Wein, Jeffrey S. Skoll Professor of Management Science, explains why childhood obesity screening may not be that useful.
A professor of organizational behavior argues that "human sustainability" may pay off too.
The success of an innovative new therapy suggests new avenues for incorporating emotional health resources into educational systems worldwide.
A physician-turned-administrator at Kaiser Permanente discusses cost-effective innovations that improve care.
How a New York-based company is trying to make surgery in the developing world a lot easier.
New and valuable mHealth apps are coming out all the time. What sort of open architecture can support this wave of innovation?
Does Medicare make a difference?
How the Positive Deviance Initiative helps communities solve their own problems
Texting emerges as a source of confirmation for drug legitimacy.
By 1998, thousands of people had contracted HIV and hepatitis C from Canada’s tainted blood supply. To restore the supply and the public’s trust, the federal, provincial, and territorial governments of Canada created a new organization, Canadian Blood Services. Despite the public health tragedy that it inherited, Canadian Blood Services rebuilt Canadians’ faith in the nation’s blood supply by infusing transparency into its structure, culture, and operations. —By Moe Abecassis, David Benjamin, & Lorna Tessier
Social media is helping people self-assemble for social action.
A look at how community advisory committees are faring in the health field.
Entrepreneurs who have gone from concept to commercialization share their experiences with breakthroughs in medical science and technology that have transformed healthcare delivery across the care continuum -- providing patients with less invasive procedures, reduced recovery times, and lower costs. Paul Yock, Professor of Medicine and Founding Co-Chair of Stanford's Program in Biodesign, leads this interactive discussion on medical device innovation at the 2011 Stanford Graduate School of Business Healthcare Summit.
The United States has been a global leader to medical technology innovation, however a changing investment environment and tougher regulatory requirements prove unique challenges for early stage innovators. From the 2011 Stanford Graduate School of Business Healthcare Summit, Stefanos Zenios, director of Stanford's GSB Program in Healthcare Innovation convenes a panel of health care investors who give those entrepreneurs starting out a full picture of the product development cycle and how to successfully raise capital.
The Veteran's Administration, Medicare, and Medicaid make up the largest repository of public health data in the world, and now it's being made available in appropriate forms for the use of patients and innovators alike. Todd Parks, CTO of the U.S. Department of Health and Human Services, wants to change the fee structure of healthcare from "Fee for Service" to something more efficient, and he's freeing up information on public health so everyone can see and help design better health systems.
How do we get individuals to practice healthier habits and influence positive behavior change? The "Behavior Wizard" offers technology-based solutions in this audio lecture from the 2011 Stanford Graduate School of Business Healthcare Summit. B.J. Fogg, Director of the Persuasive Technology Lab at Stanford University, bring his insights from the tech world. In decades studying how computers and mobile apps can be used to bring about behavior change, Fogg found new applications for the health sector in promoting positive habits.
Liberty and Justice, a for-profit, socially minded company, is creating jobs and improving health care for Liberian women
What if visiting the doctor to get a CT scan was as fun as sailing on a pirate ship? asked Doug Dietz, veteran designer of MRI and CT scan machines. Dietz had seen the widespread anxiety of children who came into the hospital and wanted to change that negative experience.
Investors provide insight on early-stage startup fundraising and advice to those interested in starting their own ventures in healthcare.
How did the global tobacco epidemic start? And what can we learn from it?
What can pharmaceutical companies do to contribute to global health?
Entrepreneurs who have gone from concept to commercialization share their experiences with breakthroughs in medical science and technology that have transformed healthcare delivery across the care continuum -- providing patients with less invasive procedures, reduced recovery times, and lower costs. Paul Yock, Professor of Medicine and Founding Co-Chair of Stanford's Program in Biodesign, leads this interactive discussion on medical device innovation at the 2011 Stanford Graduate School of Business Healthcare Summit.
Liberty and Justice, a for-profit, socially minded company, is creating jobs and improving health care for Liberian women
The United States has been a global leader to medical technology innovation, however a changing investment environment and tougher regulatory requirements prove unique challenges for early stage innovators. From the 2011 Stanford Graduate School of Business Healthcare Summit, Stefanos Zenios, director of Stanford's GSB Program in Healthcare Innovation convenes a panel of health care investors who give those entrepreneurs starting out a full picture of the product development cycle and how to successfully raise capital.
The Veteran's Administration, Medicare, and Medicaid make up the largest repository of public health data in the world, and now it's being made available in appropriate forms for the use of patients and innovators alike. Todd Parks, CTO of the U.S. Department of Health and Human Services, wants to change the fee structure of healthcare from "Fee for Service" to something more efficient, and he's freeing up information on public health so everyone can see and help design better health systems.
The Canary Fund supports the development of methods for early cancer detection. This second case presents the results of the sponsorship created to raise funding and awareness.
The Kinetics and Michael J. Fox Foundations both support research on Parkinson’s disease. This second case explores how these two organizations collaborate toward a common mission.
VaxGen is working to obtain approvals for phase III clinical trials in Thailand for an experimental vaccine against HIV. The company must cope with a host of ethical questions.
This case details the 2006 decision by the United Kingdom to deny coverage for a new form of inhaled insulin. In doing so, it highlights the challenges to innovators in managing conflicts over the costs, benefits, and risks of new technology.
In December 2004, the president of the Institute for Healthcare Improvement challenged U.S. hospitals to reduce unnecessary deaths by 100,000 in the next 18 months. The case describes a campaign that incorporated lessons from politics and social activism.
Gilead Sciences designs a strategy for delivering an AIDS drug to developing nations in Africa. This first part of the case describes the organization's initial considerations.
Gilead Sciences designs a strategy for delivering an AIDS drug to developing nations in Africa. This second part of the case explores the company’s experience with a distribution program.
Two social ventures collaborated with each other to help expand one’s solar energy services from southern Brazil into the Amazon region. The case highlights the core factors that led to the project’s ultimate outcome.
Riders for Health is a U.K.-based nonprofit dedicated to the improvement of transportation systems for health workers in Africa. In 2007, after 11 years in existence, the organization was at a critical point and had to decide what strategies were necessary to expand.
The Kinetics and Michael J. Fox Foundations both support research on Parkinson’s disease. This first case describes the creation, mission, and strategy of the two organizations.
The Canary Fund supports the development of methods for early cancer detection. This second case presents the results of the sponsorship created to raise funding and awareness.
The Kinetics and Michael J. Fox Foundations both support research on Parkinson’s disease. This second case explores how these two organizations collaborate toward a common mission.
VaxGen is working to obtain approvals for phase III clinical trials in Thailand for an experimental vaccine against HIV. The company must cope with a host of ethical questions.
This case details the 2006 decision by the United Kingdom to deny coverage for a new form of inhaled insulin. In doing so, it highlights the challenges to innovators in managing conflicts over the costs, benefits, and risks of new technology.
In December 2004, the president of the Institute for Healthcare Improvement challenged U.S. hospitals to reduce unnecessary deaths by 100,000 in the next 18 months. The case describes a campaign that incorporated lessons from politics and social activism.
Seasonal influenza leads to >200,000 hospitalizations and >8,000 deaths in the United States each year. The influenza vaccine is widely available at low cost and reduces mortality, morbidity, and healthcare costs. Nevertheless, many of those for whom vaccination is indicated fail to comply with CDC recommendations for vaccination. If low compliance is the result of careful calculations by individuals weighing the costs and benefits of vaccination, it may be difficult and expensive for policymakers and organizational leaders to increase vaccination rates. However, if low compliance is the result of forgetfulness or procrastination, low-cost interventions that use psychological tools may be effective at increasing vaccination rates and improving public health.
Evidence suggests that the medication lists of patients are often incomplete and could negatively affect patient outcomes. By predicting drugs the patient could be taking, collaborative filtering can be a valuable tool for reconciling medication lists.
Health care providers may vertically integrate not only to facilitate coordination of care, but also for strategic reasons that may not be in patients’ best interests.
Workers who earn just below the Social Security tax threshold receive a larger tax preference for health insurance than workers who earn just above it.
Young companies trying to enter parts of the health care industry by focusing on helping patients stay healthy and allowing safety net providers to use their resources have a hard time attracting venture capital funds that focus more on traditional profit. A recent article by two Stanford Graduate School of Business researchers argues that it's time to change this pattern.
The two-quarter Elective Course series provides lectures from a diverse group of faculty that expose students to the practical aspects of technology invention and development. The class features a presentation or discussion from one of the guest speakers or faculty. Students work in small project teams in the Biodesign prototyping lab or bench space, collaborating with the fellows of the program.
The purpose of this class is to provide students with the economic tools and the institutional and legal background to understand how markets for health care products and services work. The class utilizes case studies, lectures, and visits from individuals in the industry.
This course examines health care businesses and how they use technology (primarily biotechnology, medical technology, and information technology) to improve patient outcomes and manage costs. Through case studies, students gain an in-depth understanding of how new technologies get developed and commercialized in health care, and of how the whole health care value chain adapts to new technologies.
This course examines the application of cost-effectiveness and cost-benefit analysis, along with other evaluation techniques, to products and services such as medical care, whose "output" is difficult to measure. It critically reviews studies that apply cost analysis techniques to specific clinical problems.
Vision care is something that is practically taken for granted in the United States, but that’s not the case throughout much of the world. Some 300 million around the globe suffer from correctable vision loss, leading, as Ashanthi Mathai, MBA '04, says, “to people accepting their vision impairment and adjusting their lives around it.” The result? A lower quality of life, restricted job options, and even further economic distress.
Jane Chen's passion for helping others has taken her on an incredible journey from doing social work in China to founding Embrace, a company that sells premature infant incubators.
Caring for aging parents is a challenge many face, yet there is no clear path or pattern for how to manage this stage of life. Karen Routt shares her expertise at the nexus between technology and caring for the elderly.
With a high-tech background, an MBA, and an M.D., Dr. Patty Einarson has a unique perspective on the intersection of technology, business and medicine. She leverages this knowledge by contributing to math/science education in the public schools, encouraging the kids of today to become future innovators.
Mark Cafferty is passionate about empowering individuals to be all they can be. He channels funds to employment and youth service programs.
A massive South African mining conglomerate was debating how to confront the ravages of HIV/AIDS on the workforce. It considered challenges associated with launching an antiretroviral program.
The question "Will biotechnology create value?" was explored in-depth at the Stanford GSB's biotechnology conference. It often takes even large biotechnology firms years to bring a successful product to market, leaving smaller firms struggling to survive. Speakers suggest strategies such as mergers and simple patience as counteractions to the long waiting period for biotech development.
Three Stanford health policy experts tackle the challenge of making healthcare affordable; they suggest creating a health care "exchange" that offers a variety of plans, as well as the creation of a federal agency to monitor these exchanges and the rates offered. The planners believe that a variety of options will allow consumers to choose the plan that tailors best to their medical and financial needs.
Phyto-Riker, a pharmaceutical company in Ghana, contemplates the effects of the HIV epidemic in Africa on its business plans. It is not certain what resources will be available, and how they will be distributed.
In an unprecedented move in 1998, Blue Cross of California filed a citizen petition to switch three drugs to over-the-counter status. When the FDA approved, the pharmaceutical companies faced the challenge of developing a strategy for dealing with the threat.